Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is N/A as of Tuesday, October 6, 2026.
OPERATING MARGIN
N/A
Market Cap
$138.26M
Operating Margin
-3.66%
TTM Avg
-13.20%
3Y Avg
-25.26%
5Y Avg
-22.69%
Market Cap
$134.74M
Operating Margin
-7.85%
TTM Avg
-2.10%
3Y Avg
-0.51%
5Y Avg
4.29%
Market Cap
$142.11M
Operating Margin
-221.72%
TTM Avg
-110.86%
3Y Avg
-55.43%
5Y Avg
-36.95%
Market Cap
$142.49M
Operating Margin
-111.00%
TTM Avg
-151.19%
3Y Avg
-184.89%
5Y Avg
-203.40%
Market Cap
$143.81M
Operating Margin
-239.78%
TTM Avg
-210.59%
3Y Avg
-1665.90%
5Y Avg
-1977.59%
Market Cap
$130.05M
Operating Margin
-11.60%
TTM Avg
-17.18%
3Y Avg
-31.98%
5Y Avg
-39.70%
Market Cap
$129.14M
Operating Margin
-27450.00%
TTM Avg
-16372.79%
3Y Avg
-10624.45%
5Y Avg
-7949.52%
Market Cap
$128.24M
Operating Margin
-1853.92%
TTM Avg
-1829.87%
3Y Avg
-8864.53%
5Y Avg
-5959.13%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Freenome, Inc. (FRNM) | $137.29M | N/A | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $138.26M | -3.66% | -13.20% | -25.26% | -22.69% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $134.74M | -7.85% | -2.10% | -0.51% | 4.29% |
| Alpha Cognition Inc (ACOG)vs › | $142.11M | -221.72% | -110.86% | -55.43% | -36.95% |
| Fortress Biotech, Inc. (FBIOP)vs › | $142.49M | -111.00% | -151.19% | -184.89% | -203.40% |
| Korsana Biosciences, Inc. (KRSA)vs › | $143.81M | -239.78% | -210.59% | -1665.90% | -1977.59% |
| Health Catalyst, Inc. (HCAT)vs › | $130.05M | -11.60% | -17.18% | -31.98% | -39.70% |
| Entera Bio Ltd. (ENTX)vs › | $129.14M | -27450.00% | -16372.79% | -10624.45% | -7949.52% |
| Cibus, Inc. (CBUS)vs › | $128.24M | -1853.92% | -1829.87% | -8864.53% | -5959.13% |
| Immuneering Corporation (IMRX)vs › | $146.66M | 0.00% | 0.00% | -4081.44% | -3115.66% |
Gross Margin
N/A
Operating Margin
N/A
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
